Boothbay Fund Management, LLC Clearside Biomedical, Inc. Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$0.97 - $1.42 $378,300 - $553,800	-390,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.1 - $1.74 $429,000 - $678,600	390,000 New	390,000 $538,000
Q2 2018 Aug 14, 2018	SELL	$8.91 - $14.54 $129,132 - $210,728	-14,493 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$5.57 - $14.28 $80,726 - $206,960	14,493 New	14,493 $156,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $78.2M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.